Combining Radiotherapy and Immunotherapy in Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a leading cause of morbidity and mortality globally. Despite significant advances in well-established treatment techniques, prognosis for advanced-stage HNSCC remains poor. Recent, accumulating evidence supports a role for immunotherapy in HNSCC treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Runnels, Juliana, Bloom, Julie R., Hsieh, Kristin, Dickstein, Daniel R., Shi, Yuhao, Jones, Brianna M., Lehrer, Eric J., Bakst, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452591/
https://www.ncbi.nlm.nih.gov/pubmed/37626594
http://dx.doi.org/10.3390/biomedicines11082097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452591/
https://www.ncbi.nlm.nih.gov/pubmed/37626594
http://dx.doi.org/10.3390/biomedicines11082097

Ejemplares similares